This high prevalence lends further support to the potential immediate impacts of GLP-1 RAs 37 , possibly offering protection and aiding in recovery from acute insults
Its still not clinically recommended to microdose, but the dosing threshold is simpler
According to a 2025 systematic review published in Cureus, over 1,000 cases of hair loss have been reported to the FDA Adverse Event Reporting System in association with GLP-1 receptor agonists
GLP-1RAs were found to prevent progression of DR, 31 showed anti-inflammatory properties in the retina of diabetic mice, 32,33 and enhanced the vascular architecture of the retina
Fleck, Efficacy and safety of glucagon-like peptide-1/glucagon receptor co-agonist JNJ-64565111 in individuals with obesity without type 2 diabetes mellitus: A randomized dose-ranging study
In this article What Is Medical Support in Bodybuilding